GovChime
UEI: MDGNA6CW9L99 • CAGE: L7556

Retinoblastoma Solutions (ON)

Registration and award facts

SAM.gov registration as of

Net obligations since FY2008
$3.3K
$3,300under this UEI
FY2026 obligations
$0
Provisional
Awards and orders
1
with positive net obligations
Latest action
Jun 26, 2009
SAM.gov registration
Inactive
Registration expiration date May 10, 2014

Registration

Entity structure
International Organization
Business start date
Nov 12, 2002 (23 years)
Location
Toronto, ON
Purpose of registration
All Awards

† FY2026 obligations (provisional; DoD awards signed after Jul 27, 2026 are not yet public).

Contract actions that the Department of Defense both funds and awards are withheld at the source for 90 days, so DoD awards signed after Jul 27, 2026 are not yet public.

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI MDGNA6CW9L99. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2008. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2008: $3,300

Total across 1 fiscal year: $3,300

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • Q999Other medical services$3,300, 100%

Capabilities

NAICS codes

SBA certifications

No certification in the SBA profile data.

Contracts

Latest awards and orders

  1. FA304708P0435PoDepartment of DefenseDepartment of the Air ForceLatest action

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for Retinoblastoma Solutions lists a physical address and a separate mailing address, along with 6 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

399 Bathurst St Suite MP

Toronto, ON, M5T 2S8

CAN

Mailing Address

399 BATHURST ST. MP13-302

TORONTO, ON, M5T2S8

CAN

Government Business Contact

JEANNE MCKAY

399 BATHURST ST. MP 13-302

TORONTO, ON, M5T 2S8

CAN

Electronic Business Contact

JEANNE MCKAY

399 BATHURST ST. MP 13-302

TORONTO, ON, M5T 2S8

CAN

Past Performance Contact

JEANNE MCKAY

C/O TORONTO WESTERN HOSPITAL

399 BATHURST ST. MP 6-210

TORONTO, ON, M5T 2S8

CAN

Government Business Alternate Contact

FRANCES JEWETT

399 BATHURST ST. MP13-302

TORONTO, ON, M5T2S8

CAN

Electronic Business Alternate Contact

JEANNE MCCAY

399 BATHURST ST. MP13-302

TORONTO, ON, M5T2S8

CAN

Past Performance Alternate Contact

JEANNE MCKAY

C/O TORONTO WESTERN HOSPITAL

399 BATHURST ST. MP 6-210

TORONTO, ON, M5T 2S8

CAN

Additional Details

As of . Source: SAM.gov Entity Registration.

Retinoblastoma Solutions has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires May 10, 2014.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:Non-Profit Organization
Organization:Foreign Owned

Registration Details

Source: SAM.gov

Initial Registration

Mar 13, 2008

Last Update

May 10, 2014

Registration Activation

Active — May 13, 2013

Fiscal Year End

12/31

Country of Incorporation

CAN